Abstract

: This article emphasise on the Journey of Indian Pharmacopoeia and its parent organisation, the Indian Pharmacopoeia Commission (IPC) as setting up standards for maintaining the efficacy and quality of drugs used for the treatment of diseases prevailing in India. This study attempts to explore Indian Pharmacopoeial growth and general awareness among the scientists, research scholars, drug manufacturers, testing laboratories, healthcare professionals and other stakeholders for their compliance and usage. This article describe the functions of IP Commission such as revision and publication of the Indian Pharmacopoeia, addendum, National formulary of India on a regular basis also providing IP Reference Substances and professional training to the stakeholders on pertaining the Pharmacopoeial work. The objectives of the study are as follows:i. To increase awareness about the Indian Pharmacopoeia (IP) and National Formulary of India (NFI) among the stakeholders; ii. To highlight the Pharmacopoeial importance in India; iii. To discuss landscape for safety and efficacy of the medicines; iv. To explore the journey of the Indian Pharmacopoeia (IP) and National Formulary of India (NFI).This article has been brought out on the basis of evaluation of pharmacopoeial publications and recent literature published online relevant to the drug and pharmaceuticals and it is a kind of descriptive study. There is a shortage of previous similar studies observed on Pharmacopoeial importance and its compliance. It is an attempt being made to understand the drug standardization for rational use of medicine in India.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call